Rajputana Stainless IPO to hit Dalal Street on March 9, price band set at Rs 116-122 per share
Rajputana Stainless IPO | The comprises a fresh issue of 1.46 crore shares and an offer-for-sale of 62.5 lakh shares by promoter Shankarlal Deepchand Mehta.
Sedemac Mechatronics raises Rs 326 crore from 23 anchor investors; Rs 1,087-crore IPO to open on March 4
Sedemac Mechatronics IPO | Xponentia-, 360 ONE-, and A91 Partners-backed company has finalised the allocation of 24.1 lakh shares to anchor investors at the upper end of the price band.
US-Iran escalation disrupts vital trade corridors, leaving Indian pharma on edge
India exported $30.47 billion worth of pharmaceuticals in FY25, with around $1.75 billion tied to the Middle East and North Africa region, making the current situation particularly worrying
OPINION | India, China ties improve investment rules under review
India and China have improved relations since 2024. The government may ease Press Note 3 rules and introduce a de minimis threshold for smaller investments
Moneycontrol Pro Panorama | OPEC+'s paper barrels
In this edition of Moneycontrol Pro Panorama: Khamenei's death reshapes Middle East power balance, new GDP series reveals shifting sector trends, private capex revival crucial for growth momentum, and more
Artemis Medicare to raise Rs 700-crore through QIP to triple bed capacity
The Gurugram-based healthcare provider, promoted by entities linked to the Apollo Tyres Group, aims to triple its total bed capacity to between 1,700 and 2,300 by 2029
‘Pharma Has A Great Future in India Given Our Quality Of Talent & Our Low Manufacturing Cost’: Ajay Piramal
Ajay Piramal India’s undoubted M&A stalwart speaks on “Latha & the Leaders” elucidating the mantra behind his M&A success. He also elaborates on the future of his group’s 2 major verticals -pharma & finance
OPINION | India–France Tax Treaty Overhaul: Key changes investors must watch
India and France will amend their tax treaty. India will gain broader rights to tax capital gains and dividends. Anti-abuse rules will tighten and investment structures will change
Manufacturing activity surges to four-month high of 56.9 in February as factory momentum strengthens
The improvement in factory activity comes after India’s economic growth eased to 7.8 percent in the October–December quarter
OPINION | Desperately Seeking Deposits: India liquidity tight despite RBI rate cuts
Despite RBI rate cuts and liquidity support short-term rates remain high as deposit growth lags credit cash circulation rises and government balances restrict banking liquidity
OPINION | Hormuz shutdown shows why India’s energy security depends on supply diversification
In the global crude market, risk perception has an outsized influence on price trend. The outbreak of war in West Asia will have an immediate impact. India’s takeaway is to double down on its diversification strategy
IPO Action: Three new public issues to open for subscription next week with lined up of 9 listings
Nine companies are scheduled for their markets debut next week including four firms - Clean Max Enviro Energy Solutions, Shree Ram Twistex, PNGS Reva Diamond Jewellery, and Omnitech Engineering - from the mainboard segment.
GST growth hits five-month high as collections touch Rs 1.84 lakh crore in February
Gross domestic GST revenue rose 5.3 percent year-on-year to Rs 1.35 lakh crore
Rajeev Raghuvanshi gets one year extension as India’s top drug regulator
The move comes as the government keeps regular recruitment rules for the post in abeyance, signaling a preference for leadership continuity within the Central Drugs Standard Control Organization (CDSCO) amid ongoing regulatory reforms.
XED to launch GIFT City's first IPO of $12 million; public issue to open on March 6
XED Executive Development IPO | The public issue is open to eligible investors under the IFSCA framework, including Non-Resident Indians (NRIs), foreign portfolio investors, institutional investors, and other permitted overseas participants.
OPINION | Revised GDP shows three straight years of 7% plus growth, signalling underlying strength
Manufacturing powers ahead in the new series, boosting October-December quarter’s performance. A lower nominal GDP in relation to the old series may lead to a slight rise in debt-to-GDP ratio
Carbon validation and verification provider Earthood Services withdraws IPO papers
Earthood Services IPO | The public issue comprised entirely an offer-for-sale of 62.9 lakh shares, with no fresh issue component.
Abbott to distribute Novo Nordisk's semaglutide second brand Extensior in India
The companies announced that Abbott will commercialise the drug in India while Novo Nordisk supplies the molecule, which is globally known as Ozempic.
FTA will be one of the biggest game changers: Santosh Iyer, MD and CEO, Mercedes-Benz India
With clearer investment protection frameworks for European companies operating in India, the agreements could accelerate capital expenditure (capex) inflows and sustain growth momentum, Iyer said
The Reading List: February 27, 2026
Our research and opinion teams have curated a selection of articles and social media gems from the world of economy, business and finance for your weekend read
Moneycontrol Pro Panorama | Infra slowdown bites; should we worry?
In this edition of Moneycontrol Pro Panorama: India prioritises competitiveness over tariff disputes, IMF warns of fragile US growth, revised GDP series improves data precision, realty stocks rise despite slowing sales, and more
OPINION | India’s trade doctrine privileges comparative advantage over tariff asymmetries
Tariffs are increasingly a function of political cycles and their fallout. India’s negotiations are now undergirded by a coherent doctrine that builds on its core economic strengths
OPINION | A new GDP series comes in with important changes to enhance accuracy
After a decade, the GDP series is undergoing a revision. Some of the proposed changes will make for a more accurate reading of the economy but the shortcomings of the deflator will remain
GSK study flags low Shingles awareness among older Indians despite rising risk
Shingles, caused by the reactivation of the varicella‑zoster virus (VZV), typically presents as a painful rash with blisters and can lead to long‑lasting nerve pain known as post‑herpetic neuralgia (PHN). Age‑related immune decline makes adults over 50—particularly those with chronic illnesses—significantly more vulnerable.
New GDP series to rely on nearly 600 item-level deflators; older WPI series unlikely to distort growth: Statistics secretary Saurabh Garg
At the item level, both prices and methodology remain unchanged, and since the prices are already current, no significant distortion is expected, the Statistics Secretary said
